The Recall Desk
HighFDA (Drugs)·D-0063-2025·Announced 2024-12-04

Drug recall: Absorbine Jr. Ultra Strength Pain Patch manufacturing deviations

Absorbine Jr. Ultra Strength Pain Patch is being recalled nationwide due to manufacturing process deviations. The voluntary recall affects approximately 4,968,000 patches.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: This is an FDA Class II drug recall due to manufacturing process deviations with no reported illnesses or injuries. Manufacturing quality issues represent risk-of-harm products where potential harm has not yet been reported, meeting the rubric criteria for Score 3.

Plain-English summary

Absorbine Jr. Ultra Strength Pain Patch (Menthol 6.5%), manufactured by Unexo Life Sciences Private Limited and distributed by Absorbine Jr. LLC in Chattanooga, Tennessee, was recalled nationwide. Approximately 4,968,000 patches were affected.

The recall was initiated due to cGMP (current Good Manufacturing Practice) deviations, which are violations of manufacturing standards that could affect product quality, purity, or potency. This was a voluntary recall initiated by the manufacturer.

The recall was terminated in September 2025.

The recalled product

Product
ABSORBINE jr ULTRA STRENGTH PAIN PATCH, Menthol 6.5%, 1 patch per box, Distributed By: Absorbine Jr. LLC, Chattanooga, TN 37402 UPC 8 89476 41318 3, UPC 8 89476 41336 7
Manufacturer
Unexo Life Sciences Private Limited
Category
Drug — Topical Pain Relief
Hazard
  • cgmp-deviation

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • UPC 8 89476 41318 3
  • UPC 8 89476 41336 7

Distribution

Distributed nationwide across the United States.

Related recalls

Same category